Preventing MMP23-mediated cleavage of podocyte RARRES1: a novel strategy to halt chronic kidney disease progression?

Area of Science:

• Nephrology
• Molecular Biology
• Biochemistry

Background:

• Glomerular diseases and podocyte injury are primary drivers of chronic kidney disease (CKD), accounting for 80% of cases.
• Understanding the molecular mechanisms of podocyte damage is crucial for halting CKD progression.

Purpose of the Study:

• To investigate the detrimental effects of soluble retinoic acid receptor responder protein-1 (sRAR-1) cleaved by podocytes.
• To identify the specific enzyme responsible for cleaving RAR-1.

Main Methods:

• The study focused on the impact of cleaved sRAR-1 on podocytes and proximal tubular cells.
• Enzyme activity assays were performed to identify the protease responsible for RAR-1 cleavage.

Main Results:

• Podocyte-cleaved sRAR-1 exhibits harmful effects on both podocytes and proximal tubular cells.
• Matrix metalloprotease 23 (MMP-23) was identified as the enzyme that cleaves RAR-1.

Conclusions:

• MMP-23 mediated cleavage of RAR-1 contributes to kidney damage in CKD.
• These findings offer novel therapeutic targets for managing progressive kidney disease.